NeoGenomics (NEO) Earnings Date & Reports

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology... Show more

Industry: #Medical Or Nursing Services

Get AI intraday signals

A.I. Advisor

published Earnings

NEO is expected to report earnings to fall 126.75% to -1 cents per share on April 29

Q1'25

Est.

$-0.01

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

The last earnings report on February 18 showed earnings per share of 3 cents, beating the estimate of 2 cents. With 28.33K shares outstanding, the current market capitalization sits at 2.01B.

View a ticker or compare two or three

Compare

NEO